References in periodicals archive ?
Anacor is a biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform.
Voltaix is recognized worldwide as a manufacturer of specialty chemicals, with exceptional expertise in silicon, germanium and boron chemistry.
Paul's understanding of healthcare and insight into today's complex financial transactions will be valuable to Anacor as we make the transition to a publicly held company and realize the value of our boron chemistry platform through partnerships," said David Perry, President and Chief Executive Officer.